A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 39
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : PMMA
Long Form : paramethoxymethamphetamine
No. Year Title Co-occurring Abbreviation
2021 How do psychostimulants enter the human brain? Analysis of the role of the proton-organic cation antiporter. BBB, cis-inhibition, DMT, MDMA
2021 Investigation of Biotransformation Products of p-Methoxymethylamphetamine and Dihydromephedrone in Wastewater by High-Resolution Mass Spectrometry. DHM, NPS, TPs
2021 Simultaneous Quantitation of Seven Phenethylamine-Type Drugs in Forensic Blood and Urine Samples by UHPLC-MS/MS. 4-CA, 4-CMA, 4-FA, 4-FMA, LLOQ, LOD, MRM, NPSs, PMA, PMEA
2018 In Situ Determination of Illegal Drugs in Oral Fluid by Portable Capillary Electrophoresis with Deep UV Excited Fluorescence Detection. AMP, CBD, CE, FD, MDA, MDEA, MDMA, METH, PMA, THC
2017 Lack of Detection of New Amphetamine-Like Drugs Using Conventional Urinary Immunoassays. 4-FA, DOA
2017 Novel Selectivity-Based Forensic Toxicological Validation of a Paper Spray Mass Spectrometry Method for the Quantitative Determination of Eight Amphetamines in Whole Blood. 4-FA, MDA, MDEA, MDMA, PMA
2017 Studies on Para-Methoxymethamphetamine (PMMA) Metabolite Pattern and Influence of CYP2D6 Genetics in Human Liver Microsomes and Authentic Samples from Fatal PMMA Intoxications. di-OH-MA, HLMs, PMA
2016 Emerging toxicity of 5,6-methylenedioxy-2-aminoindane (MDAI): Pharmacokinetics, behaviour, thermoregulation and LD50 in rats. DIC, MDAI, s.c
2016 PKCδ knockout mice are protected from para-methoxymethamphetamine-induced mitochondrial stress and associated neurotoxicity in the striatum of mice. Iba1, PKCdelta, TNF-alpha, TUNEL
10  2016 Presentations due to acute toxicity of psychoactive substances in an urban emergency department in Switzerland: a case series. ED, NPS
11  2015 Deaths from exposure to paramethoxymethamphetamine in Alberta and British Columbia, Canada: a case series. ---
12  2014 Determination of psychostimulants and their metabolites by electrochemistry linked on-line to flowing atmospheric pressure afterglow mass spectrometry. BAM, DXM, EC, FAPA
13  2013 Analysis of new classes of recreational drugs in sewage: synthetic cannabinoids and amphetamine-like substances. PMA
14  2013 Monoamine transporter and receptor interaction profiles of a new series of designer cathinones. 3-FMC, 4-MEC, 4-MTA, DA, HEK293, MDMA, NE, PMA
15  2013 [Intoxation with paramethoxymethamphetamine]. PMA
16  2012 The antemortem neurobehavior in fatal paramethoxymethamphetamine usage. ---
17  2012 The PMMA epidemic in Norway: comparison of fatal and non-fatal intoxications. ---
18  2011 Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users. BZP, DIMS, mCPP, MDA, MDMA
19  2011 Severe paramethoxymethamphetamine (PMMA) and paramethoxyamphetamine (PMA) outbreak in Israel. CSA, PMA, PMA
20  2011 [Combination treatment of vertebral and paravertebral metastatic tumors by transarterial chemoembolization and percutaneous vertebroplasty]. CR, CT, PR, PVP
21  2010 Behavioral, hyperthermic and pharmacokinetic profile of para-methoxymethamphetamine (PMMA) in rats. ASR, GC-MS, PPI
22  2009 Studies on distribution and metabolism of para-methoxymethamphetamine (PMMA) in rats after subcutaneous administration. ---
23  2009 Studies on distribution of para-methoxymethamphetamine (PMMA) designer drug in rats using gas chromatography-mass spectrometry. PMA
24  2008 Doping control analysis of methoxyphenamine using liquid chromatography-tandem mass spectrometry. WADA
25  2007 Recent paramethoxymethamphetamine (PMMA) deaths in Taiwan. PMA
26  2006 Development of an in vitro incubation procedure for screening of CYP2D6 intrinsic clearance. GE, SS
27  2005 Metabolism of designer drugs of abuse. 4-MTA, BZP, MDPPP, MeOPP, MOPPP, MPHP, MPPP, PMA, PPP, TFMPP
28  2004 Evaluation of a procedure to assess the adverse effects of illicit drugs. GHB, MTA
29  2004 Identification of human cytochrome P450 2D6 as major enzyme involved in the O-demethylation of the designer drug p-methoxymethamphetamine. pHLMs, PM HLMs
30  2004 The designer drug situation in Ibiza. HMMA, MDA, MDEA, MDMA, MDMA, PMA
31  2003 A fatal paramethoxymethamphetamine intoxication. PMA
32  2003 New designer drug p-methoxymethamphetamine: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry. GC-MS, PMA, STA
33  2003 Paramethoxyamphetamine (PMA) poisoning; a 'party drug' with lethal effects. MDMA, PMA
34  2003 Profiling of impurities in p-methoxymethamphetamine (PMMA) by means of SPE/TLC method. Examination of the influence of experimental conditions according to 2(4) factorial. ---
35  2003 Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. BZP, mCPP, MDBP, MeOPP, MTA, PMA, TFMPP
36  2003 Synthesis of standards of the most important markers of Leuckart p-methoxymethamphetamine (PMMA). Examination of the influence of experimental conditions and a drug diluent on SPE/TLC profiling. ---
37  2003 Three fatal cases of PMA and PMMA poisoning in Denmark. MDMA, PMA
38  2001 A re-examination of the mono-methoxy positional ring isomers of amphetamine, methamphetamine and phenyl-2-propanone. MDMA, PMA
39  1999 Stimulus properties of PMMA: effect of optical isomers and conformational restriction. ---